Sign in
SCPS Stock Price, Chart, Stats & News
Scopus BioPharma Inc.
Save
Scopus BioPharma Inc. (SCPS) does not currently pay a dividend.
16,834
Market cap
–
Current P/E
–
Forward P/E
SCPS chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Scopus BioPharma Inc. is a biopharmaceutical company in the clinical development phase, dedicated to pioneering innovative treatments for serious diseases. Its core development programs are concentrated on immuno-oncology gene therapies designed to combat various forms of cancer. The company's offerings include the Duet Platform, which incorporates CpG signal transducer and activator of transcription 3 (STAT3) inhibitors.
Similar securities
Based on sector and market capitalization
Report issue